Our results support an original pro-tumorigenic role for the circadian clock circuitry in T-ALL biology and open the way to further studies focusing on the circadian transcription factors BMAL1 and CLOCK as useful biomarkers for prognostic stratification and the biological clock as potential target for innovative therapeutic strategies in T-ALL patients. The gene discussed is BMAL1; the disease is acute lymphoblastic leukemia.